Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?

Vena A, Muñoz P, Mateos M, Guinea J, Galar A, Pea F, Alvarez-Uria A, Escribano P, Bouza E.

Infect Dis Ther. 2020 Mar;9(1):137-149. doi: 10.1007/s40121-020-00280-y. Epub 2020 Feb 5.

2.

A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016.

Ercibengoa M, Càmara J, Tubau F, García-Somoza D, Galar A, Martín-Rabadán P, Marin M, Mateu L, García-Olivé I, Prat C, Cilloniz C, Torres A, Pedro-Botet ML, Ardanuy C, Muñoz P, Marimón JM.

Int J Infect Dis. 2020 Jan;90:161-166. doi: 10.1016/j.ijid.2019.10.032. Epub 2019 Nov 4.

3.

Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty FM, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shoham S, Silveira FP, Varughese C, Wilck M, Weatherby L, Oene JV, Walker AM.

J Antimicrob Chemother. 2020 Jan 1;75(1):221-228. doi: 10.1093/jac/dkz396.

PMID:
31580432
4.

A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.

Fernández-Cruz A, Semiglia MA, Guinea J, Martínez-Jiménez MDC, Escribano P, Kwon M, Rodríguez-Macías G, Chamorro-de-Vega E, Rodríguez-González C, Navarro R, Galar A, Sánchez-Carrillo C, Díez-Martín JL, Muñoz P.

Med Mycol. 2020 Apr 1;58(3):300-309. doi: 10.1093/mmy/myz060.

PMID:
31231772
5.

Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.

Galar A, Weil AA, Dudzinski DM, Muñoz P, Siedner MJ.

Clin Microbiol Rev. 2019 Feb 13;32(2). pii: e00041-18. doi: 10.1128/CMR.00041-18. Print 2019 Mar 20. Review.

6.

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution.

Galar A, Muñoz P, Valerio M, Cercenado E, García-González X, Burillo A, Sánchez-Somolinos M, Juárez M, Verde E, Bouza E.

Int J Antimicrob Agents. 2019 Jan;53(1):40-48. doi: 10.1016/j.ijantimicag.2018.09.015. Epub 2018 Sep 19.

PMID:
30243587
7.

A new cause of false positive voriconazole levels: Watch your collection tubes!

Burillo A, Gómez-López A, Escribano P, Galar A, Salinas B, Díaz-Pérez N, Muñoz P, Bouza E.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:328-331. doi: 10.1016/j.jchromb.2018.06.022. Epub 2018 Jun 13.

PMID:
29936368
8.

Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.

Galar A, Valerio M, Muñoz P, Alcalá L, García-González X, Burillo A, Sanjurjo M, Grau S, Bouza E.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00687-17. doi: 10.1128/AAC.00687-17. Print 2017 Oct.

9.

Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Johnson MG, Marty FM, Nagel J, Najdzinowicz M, Saul M, Shoham S, Silveira FP, Varughese CA, Wilck M, Weatherby L, Auton T, Walker AM.

J Antimicrob Chemother. 2016 Oct;71(10):2938-44. doi: 10.1093/jac/dkw225. Epub 2016 Jul 12.

PMID:
27407049
10.

Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.

Waks AG, Tolaney SM, Galar A, Arnaout A, Porter JB, Marty FM, Winer EP, Hammond SP, Baden LR.

Breast Cancer Res Treat. 2015 Nov;154(2):359-67. doi: 10.1007/s10549-015-3573-2. Epub 2015 Sep 29.

PMID:
26420402
11.

Serologic response to hepatitis B vaccination among lung transplantation candidates.

Galar A, Engelson BA, Kubiak DW, Licona JH, Boukedes S, Goldberg HJ, Baden LR, Marty FM, Issa NC.

Transplantation. 2014 Sep 27;98(6):676-9. doi: 10.1097/TP.0000000000000128.

PMID:
24825523
12.

Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.

Siedner MJ, Galar A, Guzmán-Suarez BB, Kubiak DW, Baghdady N, Ferraro MJ, Hooper DC, O'Brien TF, Marty FM.

Clin Infect Dis. 2014 Jun;58(11):1554-63. doi: 10.1093/cid/ciu182. Epub 2014 Mar 18.

13.

Biochemical phenotypes to discriminate microbial subpopulations and improve outbreak detection.

Galar A, Kulldorff M, Rudnick W, O'Brien TF, Stelling J.

PLoS One. 2013 Dec 31;8(12):e84313. doi: 10.1371/journal.pone.0084313. eCollection 2013.

14.

Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina.

Viñas MR, Tuduri E, Galar A, Yih K, Pichel M, Stelling J, Brengi SP, Della Gaspera A, van der Ploeg C, Bruno S, Rogé A, Caffer MI, Kulldorff M, Galas M; Group MIDAS - Argentina.

PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2521. doi: 10.1371/journal.pntd.0002521. eCollection 2013.

15.

Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.

Issa NC, Marty FM, Leblebjian H, Galar A, Shea MM, Antin JH, Soiffer RJ, Baden LR.

Biol Blood Marrow Transplant. 2014 Feb;20(2):285-7. doi: 10.1016/j.bbmt.2013.11.013. Epub 2013 Nov 22.

16.

Role of dietary polyphenols and inflammatory processes on disease progression mediated by the gut microbiota.

Martínez JA, Etxeberría U, Galar A, Milagro FI.

Rejuvenation Res. 2013 Oct;16(5):435-7. doi: 10.1089/rej.2013.1481.

PMID:
23952608
17.

Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing.

Galar A, Leiva J, Espinosa M, Guillén-Grima F, Hernáez S, Yuste JR.

J Infect. 2012 Oct;65(4):302-9. doi: 10.1016/j.jinf.2012.06.006. Epub 2012 Jun 19.

PMID:
22728132
18.

Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types.

Galar A, Yuste JR, Espinosa M, Guillén-Grima F, Hernáez-Crespo S, Leiva J.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2445-52. doi: 10.1007/s10096-012-1588-8. Epub 2012 Mar 8.

PMID:
22395261
19.

Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis.

García-Muñoz R, Rodríguez-Otero P, Galar A, Merino J, Beunza JJ, Páramo JA, Lecumberri R.

Adv Hematol. 2009;2009:173439. doi: 10.1155/2009/173439. Epub 2009 Sep 14.

20.

[Serum adiponectin and resistin level in children with idiopathic nephrotic syndrome].

Medyńska A, Kiliś-Pstrusińska K, Galar A, Zwolińska D.

Pol Merkur Lekarski. 2009 Apr;26(154):298-300. Polish.

PMID:
19580192
21.

Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).

García-Muñoz R, Galar A, Moreno C, Rodríguez-Otero P, Panizo-Morgado E, Ponz-Sarvisê M, Fernandez-Alonso M, Rubio M, Merino J, Cuesta B, Panizol C, Prosper F.

Leuk Lymphoma. 2007 Dec;48(12):2461-4. No abstract available.

PMID:
18067026
22.

[The value of the ultrasonography and computed tomography in diagnosis and monitoring of treatment of renal abscesses in children].

Zaleska-Dorobisz U, Sawicz-Birkowska K, Patkowski D, Słonina J, Galar A, Moroń K.

Pol Merkur Lekarski. 2001 Jul;11(61):44-8. Polish.

PMID:
11579830
23.

Purtscher-like retinopathy in nephrotic syndrome associated with mild chronic renal failure.

Zwolińska D, Medyńska A, Galar A, Turno A.

Pediatr Nephrol. 2000 Nov;15(1-2):82-4.

PMID:
11095019
24.

[The evaluation of the applicability of urine samples for the detection of chlamydia trachomatis antigen in children].

Choroszy-Król I, Ruczkowska J, Galar A.

Pediatr Pol. 1996 Feb;71(2):131-3. Polish.

PMID:
8966079
25.

[Prevalence of chlamydia trachomatis in the epithelial cells of the urethra in children].

Choroszy-Król I, Galar A, Ruczkowska J, Morawska Z.

Pediatr Pol. 1996 Feb;71(2):127-9. Polish.

PMID:
8966078
26.

[Urinary tract infection caused by Chlamydia trachomatis in children].

Galar A, Choroszy-Król I, Moraawska Z.

Pol Tyg Lek. 1992 Aug 7-17;47(31-33):683-5. Polish.

PMID:
1492036
27.

Bactericidal activity of serum of a child with focal proliferative glomerulonephritis.

Jankowski S, Galar A, Grzybek-Hryncewicz K, Walczuk M.

Nephron. 1991;58(4):491. No abstract available.

28.

Impaired bactericidal activity of serum of a child suffering from focal proliferative glomerulonephritis.

Jankowski S, Galar A, Grzybek-Hryncewicz K, Walczuk M.

Acta Microbiol Pol. 1991;40(1-2):65-70.

PMID:
1725093
29.

[Evaluation of bacteriologic examination of the urine of children with pyelonephritis treated during the years 1985-1986].

Morawska Z, Galar A, Piotrowska-Gede Z, Dobracka A, Jaśniak K, Miler M.

Wiad Lek. 1988 Aug 15;41(16):1077-81. Polish. No abstract available.

PMID:
3232373
30.

[Causes of acute renal failure in children].

Chatys-Górska L, Berny U, Bednorz R, Galar A, Zwolińska D, Rabczyński J.

Wiad Lek. 1980 May 15;33(10):769-75. Polish. No abstract available.

PMID:
7405209

Supplemental Content

Support Center